Suven Life Sciences Limited Share Price
Equities
SUVEN
INE495B01038
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
113 INR | +1.36% | +5.51% | +39.10% |
Sales 2022 | 120M 1.43M 114M | Sales 2023 | 136M 1.63M 130M | Capitalization | 10.57B 127M 10.12B |
---|---|---|---|---|---|
Net income 2022 | -1.22B -14.63M -1.17B | Net income 2023 | -1.18B -14.19M -1.13B | EV / Sales 2022 | 109 x |
Net cash position 2022 | 472M 5.66M 452M | Net cash position 2023 | 2.27B 27.2M 2.17B | EV / Sales 2023 | 61.1 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-7.31
x | Employees | 132 |
Yield 2022 |
1.08% | Yield 2023 |
-
| Free-Float | 28.95% |
Latest transcript on Suven Life Sciences Limited
1 day | +0.65% | ||
1 week | +5.51% | ||
Current month | +12.54% | ||
1 month | +7.18% | ||
3 months | +7.18% | ||
6 months | +48.49% | ||
Current year | +39.10% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 08/03/89 | |
M. Mohan Kumar
DFI | Director of Finance/CFO | - | 09/01/20 |
Shrenik Soni
CMP | Compliance Officer | - | 09/01/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 08/03/89 | |
Sudha Rani Jasti
FOU | Founder | 70 | 08/03/89 |
Director/Board Member | 70 | 29/04/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 113 | +1.36% | 8 642 |
26/04/24 | 111.5 | -1.52% | 17,532 |
25/04/24 | 113.2 | +0.52% | 135,373 |
24/04/24 | 112.6 | +5.00% | 48,277 |
23/04/24 | 107.2 | +0.85% | 39,928 |
Delayed Quote Bombay S.E., April 29, 2024 at 05:48 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.10% | 291M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SUVEN Stock